| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/04/2003 | US6514689 Apparatus for the measurement of preferential particle in bodily fluid |
| 02/04/2003 | US6514688 Separating, detecting or quantifying biological materials using magnetic cross-linked polyvinyl alcohol particles |
| 02/04/2003 | US6514687 Screening a candidate compound for activity as a Cytochrome P450 enzyme substrate by contacting the compound, enzyme, and a reagent chromogen comprising the ether of a phenolic dye such as a coumarin, resofurin or fluorescein dye |
| 02/04/2003 | US6514295 Precision fluorescently dyed particles and methods of making and using same |
| 02/04/2003 | CA2095633C Enrichment method for variant proteins with altered binding properties |
| 02/04/2003 | CA2060325C Polypeptides with a dopaminergic receptor activity; nucleic acids coding for these polypeptides and use of the latter for screening active substances on said polypeptides |
| 02/03/2003 | WO2002016548A2 Novel g protein-coupled receptor |
| 02/03/2003 | WO2002012553A2 Method for detecting mutations in nucleotide sequences |
| 02/03/2003 | CA2418130A1 Novel g protein-coupled receptor |
| 02/03/2003 | CA2417861A1 Method for detecting mutations in nucleotide sequences |
| 02/03/2003 | CA2391627A1 Ribosome structure and protein synthesis inhibitors |
| 01/31/2003 | WO2002012484A1 Marker for detecting plant genome polymorphism with the use of transposable element and method of constructing the same |
| 01/31/2003 | WO2002012338A2 Screening method |
| 01/31/2003 | CA2417972A1 Screening method |
| 01/31/2003 | CA2417704A1 Markers for detecting genomic polymorphisms in plant based on transposable elements and a method for producing thereof |
| 01/31/2003 | CA2391621A1 Novel variants of the human cyp2d6 gene |
| 01/31/2003 | CA2391117A1 Pde10 cell-based assay and sequences |
| 01/30/2003 | WO2003009210A1 Methods of providing customized gene annotation reports |
| 01/30/2003 | WO2003009100A2 Methods, apparatuses, and computer programs for verifying the integrity of a probe |
| 01/30/2003 | WO2003008979A2 Method to purify prion protein using nuclease |
| 01/30/2003 | WO2003008974A1 Biosensor and method for detecting analytes by means of time-resolved luminescence |
| 01/30/2003 | WO2003008973A2 Diagnostic markers for determination of the life stage of a non-human animal and classification system based thereon |
| 01/30/2003 | WO2003008969A1 Caged compound cleaving process |
| 01/30/2003 | WO2003008948A1 On-line method and equipment for detecting, determining the evolution of and quantifying a microbial biomass and other substances that absorb light along the spectrum during the development of biotechnological processes |
| 01/30/2003 | WO2003008929A2 Particle analysis as a detection system for particle-enhanced assays |
| 01/30/2003 | WO2003008649A1 Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin |
| 01/30/2003 | WO2003008647A2 Blood assessment of injury |
| 01/30/2003 | WO2003008645A1 A method for identifying mycobacterium tuberculosis and non-tuberculosis mycobacterium, together with detecting resistance to an antituberculosis drug of mycobacterium obtained by mutation of rpob gene |
| 01/30/2003 | WO2003008644A1 Method of screening abc protein promoter/inhibitor |
| 01/30/2003 | WO2003008643A2 Methods and polynukleotides for assaying the activity of a dna modifying enzyme |
| 01/30/2003 | WO2003008642A2 Amplification of nucleic acid fragments using nicking agents |
| 01/30/2003 | WO2003008641A1 Method and support for biological analysis using oligonucleotides comprising a marker capable of enzymatic activation |
| 01/30/2003 | WO2003008640A2 Asthma-associated gene |
| 01/30/2003 | WO2003008639A2 Method for detecting a nucleic acid |
| 01/30/2003 | WO2003008638A2 Sorting and immobilization system for nucleic acids using synthetic bidning systems |
| 01/30/2003 | WO2003008637A2 Use of genotyping in the individualization of therapy |
| 01/30/2003 | WO2003008636A2 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection |
| 01/30/2003 | WO2003008635A2 η-SECRETASE IN VITRO SCREENING ASSAY |
| 01/30/2003 | WO2003008634A1 Microbe examining device and method |
| 01/30/2003 | WO2003008633A1 Screening method using fish embryo |
| 01/30/2003 | WO2003008632A1 Fatty acid conjugation as a method for screening of potentially bioactive substances |
| 01/30/2003 | WO2003008630A2 Methods of profiling gene expression, protein or metabolite levels |
| 01/30/2003 | WO2003008624A2 Nucleic acid amplification using nicking agents |
| 01/30/2003 | WO2003008623A2 Methylation analysis using nicking agents |
| 01/30/2003 | WO2003008622A2 Exponential nucleic acid amplification using nicking endonucleases |
| 01/30/2003 | WO2003008581A1 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING APOPTOSIS REGULATOR |
| 01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 01/30/2003 | WO2003008578A2 Reagents and methods for identifying gene targets for treating cancer |
| 01/30/2003 | WO2003008575A2 Dna sequences for regulating transcription |
| 01/30/2003 | WO2003008574A1 Mutations in ion channels |
| 01/30/2003 | WO2003008572A1 Methods of creating genetic diversity |
| 01/30/2003 | WO2003008562A2 Methods for detecting genes associated with bone properties, height, and/or body mass properties |
| 01/30/2003 | WO2003008561A2 Genes associated with benign prostatic hyperplasia |
| 01/30/2003 | WO2003008560A2 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | WO2003008553A2 Proteins associated with cell growth, differentiation, and death |
| 01/30/2003 | WO2003008552A2 Mll translocations specify a distinct gene expression profile, distinguishing a unique leukemia |
| 01/30/2003 | WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 01/30/2003 | WO2003008542A2 Nucleic acid detection assay control genes |
| 01/30/2003 | WO2003008540A2 Abiotic stress responsive polynucleotides and polypeptides |
| 01/30/2003 | WO2003008539A2 Non-alloying core shell nanoparticles |
| 01/30/2003 | WO2003008538A2 Gene expression profiling |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008536A2 A system for intracellular process monitoring and in vivo drug screening |
| 01/30/2003 | WO2003008533A2 Method for virus propagation |
| 01/30/2003 | WO2003008532A1 Apparatus and method for analysing a biological sample in response to microwave radiation |
| 01/30/2003 | WO2003008455A1 Activity monitor molecules for g-protein trimer |
| 01/30/2003 | WO2003008449A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008074A1 Buffers for electrophoresis and use thereof |
| 01/30/2003 | WO2003007971A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | WO2003007886A2 Plant ion channels and methods |
| 01/30/2003 | WO2003007884A2 Method and reagents for identifying gene targets for treating breast cancer |
| 01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | WO2003007801A2 Diagnosis and treatment of vascular disease |
| 01/30/2003 | WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | WO2003007794A2 Invasion complex and methods of targeting |
| 01/30/2003 | WO2003007793A2 Compositions, methods, and kits related to treating and diagnosing hypertension |
| 01/30/2003 | WO2003007699A2 Transcription factors of cereals |
| 01/30/2003 | WO2003007685A2 Detecting and treating reproductive tract disorders |
| 01/30/2003 | WO2002093134A9 Method for determining the presence of infection in an individual |
| 01/30/2003 | WO2002090986A9 Colon cancer antigen panel |
| 01/30/2003 | WO2002087554A3 Ef-tu binding agent as antibacterial agent |
| 01/30/2003 | WO2002083837B1 Methods for identifying small molecules that bind specific rna structural motifs |
| 01/30/2003 | WO2002079478A3 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders |
| 01/30/2003 | WO2002058533A3 Process for determining target function and identifying drug leads |
| 01/30/2003 | WO2002051435A3 New therapeutic uses of smr1 peptides |
| 01/30/2003 | WO2002051355A3 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 01/30/2003 | WO2002048403A3 Multiplexed protein expression and activity assay |
| 01/30/2003 | WO2002048333A3 Novel human kinases and uses thereof |
| 01/30/2003 | WO2002045523A3 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/30/2003 | WO2002039113A3 Schiff base reductant co-dispense process |
| 01/30/2003 | WO2002034918A3 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 01/30/2003 | WO2002029035A3 Method to alter sugar moieties |
| 01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
| 01/30/2003 | WO2002026766A3 Haplotypes of the sstr4 gene |
| 01/30/2003 | WO2002020763A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/30/2003 | WO2002017858A3 Role of fosb in bone formation |
| 01/30/2003 | WO2002016567A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | WO2002014536A3 Odulating multiple lineage kinase proteins |
| 01/30/2003 | WO2002012553A3 Method for detecting mutations in nucleotide sequences |